Search Results 41-50 of 17024 for semaglutide

  1. Publications - W. Brian B. Beam, M.D. - Mayo Clinic

    Perioperative Considerations for Patients on Semaglutide Current Anesthesiology Reports. 2024. Warner MA, Go RS, Schulte PJ, Beam WB, Charnin JE, Meade L ...

  2. Nonalcoholic Fatty Liver Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to investigate the effectiveness and safety of three dose levels of subcutaneous semaglutide for the treatment of patients who ...

  3. Publications - Ana-Maria Chindris, M.D. - Mayo Clinic

    Grennan KN, Singh D, Chindris AM, Wilson JR. A Case of Oral Semaglutide for Treatment of Hepatocyte Nuclear Factor 4A Maturity-Onset Diabetes of the Young.

  4. Mayo Clinic Minute: Weaning off popular weight-loss medications Video Audio

    You step on the scale and the numbers are moving in the right direction after taking one of the popular injectable weight-loss drugs.

  5. Publications - Dominika A. Jegen, M.D. - Mayo Clinic

    ... semaglutide therapy following bariatric surgery. Endocrinol Diabetes Metab Case Rep. 2025 Jul 1; 2025 (3) Epub 2025 Sept 16. View PubMed; Jegen D. Navigating ...

  6. Glecaprevir and pibrentasvir (oral route) - Mayo Clinic

    Semaglutide; Sitagliptin; Tolazamide; Tolbutamide; Voglibose. Other Interactions. Certain medicines should not be used at or around the time of eating food or ...

  7. Dulaglutide (subcutaneous route) - Mayo Clinic

    Semaglutide; Sotalol; Timolol. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food ...

  8. Selective use of cortical-sparing adrenalectomy for pheochromocytoma - Mayo Clinic

    In cortical-sparing bilateral adrenalectomy, some cortical adrenal tissue is preserved, sparing patients the dependency of exogenous steroids and potential ...

  9. Pseudotumor cerebri (idiopathic intracranial hypertension) - Diagnosis & treatment - Mayo Clinic

    Weight-loss medicines. Newer weight-loss medicines may be recommended to help treat IIH. Glucagon-like peptide 1 (GLP-1) receptor agonists such as semaglutide ( ...

  10. Publications - Jessica R. Wilson, M.D. - Mayo Clinic

    Grennan KN, Singh D, Chindris AM, Wilson JR. Hypokalemia Requiring Hospitalization After Taking Semaglutide Injections. Cureus. 2025 Jul; 17 (7):e87382 Epub ...